Nasal Drug Delivery Market Size, Share, Opportunities, And Trends By Dosage Form (Nasal Spray, Nasal Drops, Nasal Ointment, Others), By Application (Disease Treatment, Research/Academic purposes), And By Geography - Forecasts From 2025 To 2030

  • Published : May 2025
  • Report Code : KSI061614741
  • Pages : 147
excel pdf power-point

Nasal Drug Delivery Market Size:

The Nasal Drug Delivery Market is expected to grow from US$73.465 billion in 2025 to US$100.323 billion in 2030, at a CAGR of 6.43%.

Nasal drug delivery is referred to the transfer of drugs into the human body through an intranasal route of administration. These are in high demand owing to the convenience of administration in addition to providing improved patient compliance. Also, there are certain drugs that are not suitable for oral or parenteral administration, thus, calling for the need for nasal drug delivery systems. Furthermore, rising R&D investment, and growing health expenditure are driving the growth of the global nasal drug delivery market in the forecast period.

Nasal Drug Delivery Market Drivers:

  • Non-suitability of certain drugs via the oral or parenteral route of administration.
  • Increasing health expenditure worldwide.

Nasal Drug Delivery Market Restraints:

  • Stringent regulations regarding the approval of drugs and medical devices.

The major players profiled in the nasal drug delivery market include OptiNose, Inc., Korten Pharmaceuticals Pvt. Ltd., Catalent, Inc, Cipla Inc., and Perrigo Company plc.

Nasal Drug Delivery Market Scope:

 

Report Metric Details
Nasal Drug Delivery Market Size in 2025 US$73.465 billion
Nasal Drug Delivery Market Size in 2030 US$100.323 billion
Growth Rate CAGR of 6.43%
Study Period 2020 to 2030
Historical Data 2020 to 2023
Base Year 2024
Forecast Period 2025 – 2030
Forecast Unit (Value) USD Billion
Segmentation
  • Dosage Form
  • Application
  • Geography
Geographical Segmentation North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in Nasal Drug Delivery Market
  • OptiNose, Inc.
  • Korten Pharmaceuticals Pvt. Ltd.
  • Catalent, Inc
  • Cipla Inc.
  • Perrigo Company plc
Customization Scope Free report customization with purchase

 

The nasal drug delivery market is analyzed into the following segments:

By Dosage Form

Nasal Spray

Nasal Drops

Nasal Ointment

Others

 

By Application

Disease Treatment

Research/Academic purposes

 

By Geography

North America

USA

Canada

Mexico

 

South America

Brazil

Argentina

Others

 

Europe

United Kingdom

Germany

France

Others

 

Middle East and Africa

Saudi Arabia

UAE

Israel

Others

 

Asia Pacific

China

India

Australia

South Korea

Others


Frequently Asked Questions (FAQs)

Q1. What will be the nasal drug delivery market size by 2024?
A1. The nasal drug delivery market is projected to reach a total market size of US$76.083 billion by 2024.

Q2. What is the size of global nasal drug delivery market?
A2. Nasal Drug Delivery market was valued at US$51.917 billion in 2018. 

Q3. What are the growth prospects for nasal drug delivery market?
A3. The global nasal drug delivery market is projected to grow at a CAGR of 6.58% over the forecast period.

Q4. What factors are anticipated to drive the nasal drug delivery market growth?
A4. Rising R&D investment, growing health expenditure are driving the growth of the global nasal drug delivery market in the forecast period.

Q5. Who are the major players in the nasal drug delivery market?
A5. The major players profiled in the nasal drug delivery market include OptiNose, Inc., Korten Pharmaceuticals Pvt. Ltd., Catalent, Inc, Cipla Inc., and Perrigo Company plc.


Frequently Asked Questions (FAQs)

The nasal drug delivery market is expected to reach a total market size of US$100.323 billion by 2030.

Nasal Drug Delivery Market is valued at US$73.465 billion in 2025.

The nasal drug delivery market is expected to grow at a CAGR of 6.43% during the forecast period.

The North American region is anticipated to hold a significant share of the nasal drug delivery market.

The nasal drug delivery market is expected to grow due to rising demand for non-invasive treatments, advancements in nasal spray tech, and increasing prevalence of chronic diseases.

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Currency

1.5. Assumptions

1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY 

2.1. Research Design

2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Segmentation

4.2. Market Drivers

4.3. Market Restraints

4.4. Market Opportunities

4.5. Porter’s Five Force Analysis

4.5.1. Bargaining Power of Suppliers

4.5.2. Bargaining Power of Buyers

4.5.3. Threat of New Entrants

4.5.4. Threat of Substitutes

4.5.5. Competitive Rivalry in the Industry

4.6. Life Cycle Analysis - Regional Snapshot

4.7. Market Attractiveness

5. NASAL DRUG DELIVERY  MARKET BY DOSAGE FORM

5.1. Nasal Spray

5.2. Nasal Drops

5.3. Nasal Ointment

5.4. Others

6. NASAL DRUG DELIVERY  MARKET BY APPLICATION

6.1. Disease Treatment

6.2. Research/Academic purposes

7. NASAL DRUG DELIVERY  MARKET BY GEOGRAPHY

7.1. North America

7.1.1. USA

7.1.2. Canada

7.1.3. Mexico

7.2. South America

7.2.1. Brazil

7.2.2. Argentina

7.2.3. Others

7.3. Europe

7.3.1. United Kingdom

7.3.2. Germany

7.3.3. France

7.3.4. Others

7.4. Middle East and Africa

7.4.1. Saudi Arabia

7.4.2. UAE

7.4.3. Israel

7.4.4. Others

7.5. Asia Pacific

7.5.1. China

7.5.2. India

7.5.3. Australia

7.5.4. South Korea

7.5.5. Others

8. COMPETITIVE INTELLIGENCE

8.1. Company Benchmarking and Analysis

8.2. Recent Investment and Deals

8.3. Strategies of Key Players

9. COMPANY PROFILES

9.1. OptiNose, Inc.

9.2. Korten Pharmaceuticals Pvt. Ltd.

9.3. Catalent, Inc

9.4. Cipla Inc.

9.5. Perrigo Company plc

LIST OF FIGURES

LIST OF TABLES

OptiNose, Inc.

Korten Pharmaceuticals Pvt. Ltd.

Catalent, Inc

Cipla Inc.

Perrigo Company plc